Background: Though postoperative acute pain following third molar extraction impairs patient satisfaction and increases healthcare costs, evidence regarding the efficacy of the highly selective cyclooxygenase-2 (COX-2) inhibitor etoricoxib for preemptive analgesia in this setting remains unclear. Purpose:The purpose of this study was to measure the association of etoricoxib preemptive analgesia on pain and functional recovery after third molar surgery.
Li et al. (Sun,) studied this question.